4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE (ARTFORCE)
Date du début: 1 avr. 2011, Date de fin: 30 sept. 2017,
...oxic treatments and redistribution of dose.3 decrease community costs by reserving expensive treatments for those who will benefit.This will be studied in randomized phase II clinical trials in top European institutes, followed by phase III trials outside this proposal.
Voir le projet
14
Participants partenaires
TERMINÉ
Multidisciplinary evaluation of the cancer risk from neutrons relative to photons using stem cells and the induction of second malignant neoplasms following paediatric radiation therapy (ANDANTE)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,
The ANDANTE project will investigate the relative risk of neutrons compared to photons for tumorigenesis, as a function of dose and energy. The approach will be multidisciplinary, including physics measurements and modelling, molecular biology, radiobiology, and epidemiology. The relative risk of neutrons will be studied using human and animal stem cells irradiated with either photons or neutron ...
Voir le projet
9
Participants partenaires
TERMINÉ
Union of Light-Ion Centres in Europe (ULICE)
Date du début: 1 sept. 2009, Date de fin: 31 août 2014,
ULICE is a 4-year project set up by 20 leading European research organisations, including 2 leading European industrial partners (Siemens and IBA), to respond to the need for greater access to hadron therapy facilities for particle therapy research. Project coordinator is the Italian Research Infrastructure Facility CNAO (Milan). Both existing European Hadron Research Facilities in Heidelberg and ...
Voir le projet
20
Participants partenaires
TERMINÉ
Early and late health risks to normal/healthy tissues from the use of existing and emerging techniques for radiation therapy (ALLEGRO)
Date du début: 1 févr. 2009, Date de fin: 31 mars 2011,
Curative cancer treatment with radiation seeks to optimise the magnitude of the radiation dose to the treatment volume while restricting the dose to normal healthy tissue. With an increasing population of surviving cancer patients treated with radiation therapy, the harmful effects of the radiation to normal tissue are becoming more evident. The ALLEGRO project will address the many aspects of n ...
Voir le projet